Source: Personal communication, PharmaTimes
Bayer has announced the UK launch of aflibercept (Eylea®) solution for injection, for the treatment of wet age-related macular degeneration. According to the SPC, treatment is initiated with one 2mg injection per month for three months, followed by one injection every 2 months. After the first 12 months, the treatment interval may be extended based on visual and anatomic outcomes.
Aflibercept is available in vials of 4mg (100 microlitres; cost of £816 per vial), intended to provide a usable amount to deliver a (Read more...)